Company Performance: Positive earnings reports, successful clinical trials, and new product approvals can increase investor confidence and drive up the stock price.

Industry Trends: Positive developments in the vaccine industry, such as increased government funding or a rise in infectious disease outbreaks, can positively impact IVACC.ST.

Market Sentiment: Overall investor optimism or pessimism regarding the stock market and biotechnology sector can influence the demand for IVACC.ST shares.

Regulatory Environment: Changes in regulations related to drug approvals, pricing, or intellectual property can impact the company's profitability and stock price.

Competition: The emergence of new competitors or the success of existing rivals can affect IVACC.ST's market share and investor perception.

Macroeconomic Factors: Economic growth, interest rates, and inflation can all influence investor decisions and the overall stock market, including IVACC.ST.

Global Health Crises: Pandemics or epidemics can create significant demand for vaccines, potentially boosting IVACC.ST's revenue and stock price.

Investor Perception of Risk: The inherent risks associated with biotechnology companies, such as clinical trial failures or regulatory setbacks, can affect investor willingness to invest in IVACC.ST.

News and Events: Major announcements, such as partnerships, acquisitions, or product recalls, can cause fluctuations in the stock price.

Technological Advancements: Breakthroughs in vaccine technology or manufacturing processes can give IVACC.ST a competitive advantage and attract investors.